Relafin is a common misspelling of Relafen (nabumetone).
The Relafen brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
What is Relafen (Relafin)?
Relafen (Relafin) belongs to a family of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). Relafen (Relafin) works by blocking certain substances and hormones that cause inflammation and pain in the body.
Relafen (Relafin) is used to relieve the inflammation, swelling, stiffness and joint pain associated with rheumatoid arthritis and osteoarthritis (the most common form of arthritis). It does not treat the underlying disease that causes these symptoms. Relafen (Relafin) may also be used for other conditions as determined by your doctor.
Relafen (Relafin) may occasioanlly cause serious bleeding from the stomach or intestines. Also, related drugs rarely have caused blood clots to form, resulting in heart attacks and strokes. Relafen (Relafin) might also rarely cause similar problems.
Click for more information on Relafin (Relafen)
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.